[18F]-FAPI-42 versus [18F]-FDG in detecting viable tumors of moderately to poorly differentiated hepatocellular carcinoma
In a retrospective study of 35 patients with moderately to poorly differentiated hepatocellular carcinoma, [18F]-FAPI-42 PET/CT demonstrated significantly superior detection rates for viable tumors compared to [18F]-FDG PET/CT, particularly for intrahepatic lesions and distant metastases to the peritoneum, lung, and bone, while [18F]-FDG showed higher sensitivity for lymph node metastases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine you are trying to find hidden treasure (viable cancer cells) inside a complex, messy landscape (a liver that has been treated with surgery, radiation, or drugs). The landscape is full of "scars," "debris," and "false alarms" that look suspicious but aren't actually the treasure you are hunting for.
This study is a head-to-head competition between two different "scouts" (imaging tracers) sent to find this treasure in patients with a specific type of liver cancer called moderately to poorly differentiated hepatocellular carcinoma (mp-HCC).
Here is the breakdown of the two scouts and how they performed:
The Two Scouts
The Old Scout ([18F]-FDG): This is the traditional method. It looks for sugar. Cancer cells are greedy and eat a lot of sugar, so this scout lights up where sugar consumption is high.
- The Problem: After cancer treatment, the liver often has inflammation or scarring that also eats sugar, creating "false alarms." Also, some stubborn cancer cells stop eating sugar as aggressively, making them invisible to this scout.
The New Scout ([18F]-FAPI-42): This is the modern method. It looks for construction workers (specifically, cells called Cancer-Associated Fibroblasts). Even when the main "criminals" (cancer cells) are hiding or shrinking, the "construction crew" (the tumor's support structure) often stays behind or even grows to help the tumor resist treatment. This scout lights up where these construction workers are.
The Results: Who Found More Treasure?
The study looked at 35 patients who had already undergone cancer treatment. Here is what happened:
1. Inside the Liver (The Main Battlefield)
- The Winner: The New Scout ([18F]-FAPI-42).
- The Story: The New Scout found 96% of the hidden tumors, while the Old Scout only found 33%.
- Why? The Old Scout got confused by the "noise" of the liver background (which glows with sugar). The New Scout had a much clearer view because the normal liver didn't light up as much, making the tumors stand out like bright beacons. It was especially good at finding tiny tumors (even those smaller than a marble) that the Old Scout missed completely.
2. Distant Treasures (Lungs, Bones, Peritoneum)
- The Winner: The New Scout ([18F]-FAPI-42).
- The Story: When the cancer spread to the lining of the belly (peritoneum), the lungs, or the bones, the New Scout found 94% of these spots, while the Old Scout only found 50%.
- The Bone Analogy: Finding cancer in the bone with the Old Scout is like trying to find a black cat in a dark room full of other black cats (because healthy bone marrow also eats sugar). The New Scout is like a spotlight that only shines on the cat, making it impossible to miss.
3. The One Area Where the Old Scout Won: The Lymph Nodes
- The Winner: The Old Scout ([18F]-FDG).
- The Story: Surprisingly, when the cancer spread to the lymph nodes (the body's drainage system), the Old Scout found 96% of them, while the New Scout only found 69%.
- The Reason: It seems that in the lymph nodes, the cancer cells might not have as many "construction workers" (FAP) as they do in the liver, or the sugar-eating activity is just stronger there. This suggests the two scouts are complementary, not interchangeable. You need both to be sure you haven't missed anything.
The "False Alarm" Issue
The New Scout is so sensitive that it sometimes gets excited by things that aren't the main treasure.
- The Glitch: In 15 patients, the New Scout found "glowing spots" in the liver that turned out to be scars or inflammation from previous treatments (like surgery cuts or radiation burns), not active cancer.
- How to tell the difference: While the "brightness" (SUVmax) of these false alarms looked similar to real tumors, their shape and location gave them away. Real tumors usually look like distinct lumps, while the false alarms looked like rings, strips, or flakes along the edges of where surgery or treatment happened.
The Bottom Line
- For the Liver and Distant Spots: The New Scout ([18F]-FAPI-42) is a much better detective. It finds more tumors, especially small ones and those in the liver, lungs, and bones, even in patients who don't have high levels of a blood marker called AFP.
- For Lymph Nodes: The Old Scout ([18F]-FDG) is still the better detective.
- The Catch: The New Scout has a higher rate of "false alarms" in the liver due to treatment scars, but doctors can usually tell the difference by looking at the shape of the glow.
In summary: If you want to find the most viable cancer cells after treatment, the New Scout is generally superior, but you should probably keep the Old Scout in your pocket just in case the cancer has spread to the lymph nodes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.